title: A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival.
abstract: Eighty-five renal transplant recipients were prospectively monitored for CMV infection up to 4 months post-transplantation by virus isolation from leukocytes, CMV antigen detection (pp65) in peripheral blood leukocytes (PBL), polymerase chain reaction (PCR) of alkaline treated plasma (P-PCR), PCR of extracted DNA from PBL (L-PCR) and serology. Additionally univariate and multivariate analyses of risk factors for patient and graft survival up to 4 yr post-transplantation were performed. The incidence of CMV infection was 78% and of CMV disease 33%. Antigen detection in PBL was positive before or at onset of symptoms in 23/24 (96%) evaluable patients with CMV disease. The corresponding figures for virus isolation were 22/24 (92%), P-PCR 21/24 (88%) and for L-PCR 18/24 (75%). The percentage of negative samples in patients without CMV disease was 89% for the antigen test, 92% for L-PCR and 83% for virus isolation and P-PCR. One rapid test (antigen test, P-PCR or L-PCR) was positive at a median of 16 d before the onset of symptoms. The antigen test was generally the first rapid test to become positive. CMV disease did not affect graft survival in the multivariate analysis but was associated with decreased patient survival.
authors.affiliation: Department of Infectious Diseases, University Hospital, Uppsala, Sweden.
authors.forename: B M
authors.initials: BM
authors.lastname: Eriksson
authors.forename: B Z
authors.initials: BZ
authors.lastname: Wirgart
authors.forename: K
authors.initials: K
authors.lastname: Claesson
authors.forename: G
authors.initials: G
authors.lastname: Tufveson
authors.forename: G
authors.initials: G
authors.lastname: Magnusson
authors.forename: T
authors.initials: T
authors.lastname: Tötterman
authors.forename: L
authors.initials: L
authors.lastname: Grillner
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D000956:Antigens, Viral / Q000097:blood; D002648:Child; D003587:Cytomegalovirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D003586:Cytomegalovirus Infections / Q000097:blood / Q000175:diagnosis*; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D015994:Incidence; D016030:Kidney Transplantation; D007962:Leukocytes / Q000821:virology; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D010750:Phosphoproteins / Q000276:immunology; D016133:Polymerase Chain Reaction; D011446:Prospective Studies; D012307:Risk Factors; D012680:Sensitivity and Specificity; D015996:Survival Rate; D014763:Viral Matrix Proteins / Q000276:immunology; D014766:Viremia / Q000382:microbiology*
chemical_list: D000956:Antigens, Viral; D004279:DNA, Viral; D010750:Phosphoproteins; D014763:Viral Matrix Proteins; C065418:cytomegalovirus matrix protein 65kDa